Review Article
Limbal Stem Cell Deficiency: Current Treatment Options and Emerging Therapies
Table 4
Published clinical outcomes of SLET.
| | Patients | Type of graft | Substrate | Success rate | 2-line visual improvement | Subsequent surgery | Complications | Follow-up (months) | | Mean | Range |
| | Amescua et al. [95] | 4 | Autograft | HAM | 100% (4/4) | 100% (4/4) | — | — | 7.5 | 6–9 | | Bhalekar et al. [96] | 1 | Allograft | HAM | 100% (1/1) | 100% (1/1) | — | Rejection | 6 | — | | Bhalekar et al. [119] | 1 | Autograft | HAM | 100% (1/1) | 100% (1/1) | — | — | >1 | — | | Bhalekar et al. [120] | 1 | Autograft | HAM | 100% (1/1 | 100% (1/1) | — | Epithelial plaque hyperplasia | 14 | — | | Vazirani et al. [97] | 1 | Autograft | HAM | 100% (1/1) | 100% (1/1) | Graft redo, conjunctival autografting | — | 6 | — | | Sangwan et al. [94] | 6 | Autograft | HAM | 100% (6/6) | 100% (6/6) | — | — | 9.2 | 4–48 |
| | Overall | 14 | | | 100% | 100% | | | 8 | 4–48 |
|
|
HAM: human amniotic membrane.
|
